期刊文献+

用ITS和TUB序列差异鉴定临床相关波氏假阿利什霉/尖端赛多孢 被引量:2

Identification of PeudaUescheria boydii/Scedosporium apiospermum clinical isolates by sequence differences of ITS and TUB
原文传递
导出
摘要 目的 探讨用rDNA基因ITS及TUB的差异对15株致病性波氏假阿利什霉/尖端赛多孢重新分类鉴定,以了解致病菌株种类及指导临床治疗的意义.方法 对15株北京大学真菌与真菌病研究中心保存的临床相关波氏假阿利什霉/尖端赛多孢采用形态学方法观察菌落形态及显微镜下特征,糖同化试验方法观察菌株对D-核糖的利用,以及对菌株ITS及TUB进行Clustal X序列比对和MEGA 4方法种系发生研究.结果 15株波氏假阿利什霉/尖端赛多孢菌落形态学和显微镜特征无明显差异,仅1株出现有性期表现.糖同化试验显示所有菌株均可利用D-核糖.15株菌经与荷兰CBS网站(http://www.cbs.knaw.nl)数据库中模式株比对以及绘制种系发生图,显示分属于波氏假阿利什霉复合种第4支Scedosporium apiospermum和第5支Pseudallescheria boydii,且分别为4和11株.结论 对于波氏假阿利什霉复合种仅依赖形态学和生理生化特征难以准确鉴定,且耗时长,而通过多位点基因片段序列分析能可靠鉴定波氏假阿利什霉/尖端赛多孢.对临床相关的波氏假阿利什霉/尖端赛多孢建议在形态学基础上结合分子方法进行种水平鉴定. Objective To re-identify fifteen clinical Pseudallescheria boydii/Scedosporium apiospermum isolates by the sequence difference of ITS rDNA and partial β-tubulin gene (TUB) and thus understand the pathogenic strain types for guiding the clinical treatment.Methods Morphological appearances,D-ribose assimilation and sequencing of ITS and TUB were used to re-identify the fifteen clinical strains of Pseudallescheria boydii/Scedosporium apiospermum.The sequences of ITS and TUB were analyzed with Clustal X and MEGA 4 software.Results No difference of morphological appearances was found in the fifteen strains.Cleistothecium was observed in one isolate.All the strains were D-ribose assimilation positive.The clinical strains were re-identified as P.boydii species complex by the CBS database (http://www.cbs.knaw.nl). Eleven strains were P.boydii and four strains were S.apiospermum respectively.Conclusions P.boydii and S.apiospermum cannot be identified correcdy by the time-consuming conventional morphological method and biochemical characteristics.The study recommend that the clinical isolates of P.boydii and S.apiospermum should be identified utilizing a combination of traditional phenotype method and molecular biotechnology.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2011年第12期1084-1087,共4页 Chinese Journal of Laboratory Medicine
关键词 波氏假阿利什霉/尖端赛多孢 核糖体DNA 微管蛋白 Pseudallescheria boydii/ Scedosporium apiospermum rDNA Tubulin
  • 相关文献

参考文献15

  • 1Cortez KJ,Roilides E,Quiroz-Telles F,et al.Infections Caused by Scedosporium spp.Clin Microbial Re,2008,21:157-197.
  • 2Borman AM,Campbell CK,Linton CJ,et al.Polycytella hominis is a mutated form of Scedosporium apiospermun. Med Mycol,2006,44:33-39.
  • 3Gilgado F,Cano J,Gené J,et al. Different virulence of the species of the Pseudallescheria boydii complex.Med Mycol,2009,47:371-374.
  • 4Gilgado F,Serena C,Cano J,et al.Antifungal susceptibilities of the species of the Pseudallescheria boydii complex. Antimicrob Agents Chemother,2006,50:4211-4213.
  • 5Kaltseis J,Rainer J,De Hoog GS.Ecology of Pseudallescheria and Scedosporium species in human-dominated and natural environments and their distribution in clinical samples. Med Mycol,2009,47:398-405.
  • 6Van Burik JA,Schreckhise RW,White TC,et al.Comparison of six extraction techniques for isolation of DNA from filamentous fungi.Med Mycol,1998,36:299-303.
  • 7White TJ,Bruns T,Lee S,et al. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics.//Innis MA,Gelfand DH,Sninsky JJ,et al.PCR protocols:a guide to the methods and applications. New York:Academic Press,1990:315-322.
  • 8Cruse M,Telerant R,Gallagher T,et al. Cryptic species in Stach ybotrys chartarum.Mycologia,2002,94:814-822.
  • 9Gilgado F,Cano J,Gené J,et al.Molecular Phylogeny of the Pseudallescheria boydii Species Complex:Proposal of Two New Species.J Clin Microbiol,2005,43:4930-4942.
  • 10Gilgado F,Gené J,Cano J,et al.Heterothallism in Scedosporium apiospermum and description of its teleomorph Pseudallescheria apiosperma sp.nov.Med Mycol,2010,48:122-128.

二级参考文献7

  • 1Conez KJ,Roilides E,Quiroz-Telles F,et al.Infections caused by Scedosporium spp[J].Clin Microbiol Re,2008 ; 21:157-197.
  • 2Denning DW.Echinocandin antifungal drugs[J].Lancet,2003;362:1142-1151.
  • 3Cuenca-Estrella M,Alastruey-Izquierdo A,Alcazar-Fuoli L,et al.In vitro activities of 35 double combinations of antifungal agents against Scedosporium apiospermum and Scedosporium prolificans[J].Antimicrob Agents Chemother,2008 ; 52:1136-1139.
  • 4Kurtz MB,Heath IB,Marrinan J,et al.Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3) beta-D-glucan synthase[J].Antimicrob Agents Chemother,1994; 38:1480-1489.
  • 5Cuenca-Eatrella M,Gomez-Lopez A,Garcia-Effron G,et al.Combined activity in vitro of caspofungin,amphotericin B,and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus[J].Antimicrob Agents Chemother,2005; 49:1232 -1235.
  • 6Cuenca-Estrella M,Gomez-Lopez A,Buitrago MJ,et al.In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevrcaulis[J].Antimicrob Agents Chemother,2006 ; 50:2248-2250.
  • 7Shalit I,Shadkchan Y,Samra Z,et al.In vitro synergy of caspofungin and itraconazole against Aspergillus spp.:MIC versus minimal effective concentration end points[J].Antimicrob Agents Chemother,2003 ; 47:1416 -1418.

共引文献5

同被引文献29

  • 1王澎,徐英春,窦洪涛,谢秀丽,王辉.尖端赛多孢和多育赛多孢所致的深部真菌感染2例并文献复习[J].中国真菌学杂志,2007,2(4):210-213. 被引量:14
  • 2Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases[J]. Clin Infect Dis, 2005, 41(5): 634-653.
  • 3Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease[J]. Clin Microb Rev, 2000, 13(2): 236-301.
  • 4Torres HA, Hachem RY, Chemaly RF, et al. Posaconazole: a broad-spectrum triazole antifungal[J]. Lancet Infect Dis, 2005, 5(12): 775-785.
  • 5Rodríguez, MM, Serena C, Mariné M, et al. Posaconazole combined with amphotericin B, an effective therapy for a murine disseminated infection caused by Rhizopus oryzae[J]. Antimicrob Agents Chemother, 2008, 52(10): 3786-3788.
  • 6Sun QN, Najvar LK, Bocaneqra R, et al. In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model[J]. Antimicrob Agents Chemother, 2002, 46(7): 2310-2312.
  • 7Kontoyiannis DP, Lewis RE. How I treat mucormycosis[J]. Blood, 2011, 118(5):1216-1224.
  • 8Barry AL, Pfaller MA, Brown SD, et al. Quality control limits for broth microdilution susceptibility tests of ten antifungal agents[J]. J Clin Microbiol, 2000, 38(9):3457-3459.
  • 9lvarez E, Cano J, Stchiqel AM, et al. Two new species of Mucor from clinical samples[J]. Med Mycol, 2011, 49(1):62-72.
  • 10Schell WA, O'Donnell K,Alspaugh JA. Heterothallic mating in Mucor irregularis and first isolate of the species outside of Asia[J]. Med Mycol, 2011, 49(7): 714-723.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部